Humana has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice to divest a majority interest in Humana’s Kindred at Home subsidiary, KAH Hospice. 

Under the agreement, Humana will divest a 60% interest in KAH Hospice and receive cash proceeds of approximately $2.8 billion.